RESUMO
The consumption of edible-culinary mushrooms for the prevention and treatment of chronic disease has gained increasing attention. This review summarizes trends in the biotechnological and medicinal potential of edible mushrooms cultivated worldwide. Macronutrients (fatty acids, amino acids, and carbohydrates), bioactive compounds (phenolics, flavonoids, and carotenoids), and health benefits (antioxidant, antimicrobial, antifungal, anticancer, and pre-biotics properties) of mushrooms are described, including their cultivation, industrial processing, and consumption. In general, edible-culinary mushrooms present a rich nutritional composition with beneficial properties for human health. Indeed, the consumption of edible mushrooms is associated with a reduction in the risk of cancer and diabetes. Furthermore, mushrooms can be incorporated into different food formulations and used as a medicinal substance due to their mycochemicals with antioxidant capacity. Edible mushrooms are considered a "superfood" and can be recommended as a valuable constituent in the daily diet. In conclusion, this review describes trends, future decision-making, and guidance on the health benefits of edible mushrooms.
Assuntos
Agaricales , Agaricales/química , Antioxidantes/química , Carotenoides , Flavonoides , Humanos , FenóisRESUMO
In this research paper we describe the technological properties of beneficial lactic acid bacteria (LAB) obtained from a dairy production chain and the development of a fermented milk produced with Lactobacillus casei MRUV6. Fifteen LAB isolates (Lactobacillus sp., Pediococcus sp. and Weissela sp.) presented acidifying abilities (pH ranges from 0.73 to 2.11), were able to produce diacetyl (except by 5 isolates) and exopolysaccharides, and two were proteolytic. L. casei MRUV6 was selected for producing a fermented milk, stored up to 35 d at 4 and 10°C. Counts on MRS agar with added vancomycin (10 mg/l) and MRS agar with added bile salts (1.5% w/v) ranged from 9.7 to 9.9 log CFU/g, independently of the tested conditions, indicating stability and intestinal resistance of L. casei MRUV6, despite some significant differences (P < 0.05). The study demonstrated the technological potential of a potential probiotic candidate strain, L. casei MRUV6, to be used as a starter culture in the dairy industry.
Assuntos
Produtos Fermentados do Leite/microbiologia , Lacticaseibacillus casei/fisiologia , Probióticos/administração & dosagem , Animais , Manipulação de Alimentos/métodos , Tecnologia de Alimentos , Concentração de Íons de Hidrogênio , Lactobacillus/fisiologiaRESUMO
BACKGROUND: Consumers are increasingly demanding for natural and beneficial foods, in order to improve their health and well-being. Probiotics play an important role in such demand, and dairy foods are commonly used as vehicles for such bacteria, represented predominantly by lactic acid bacteria. Due to consumers demand, food industry is constantly looking for novel bacterial strains, leading to studies that aims the isolation and characterization of their beneficial features. This study aimed to characterize the naturally occurring lactic acid bacteria obtained from a dairy environment, in order to assess their potential use as probiotics. RESULTS: Preliminary screening and PCR analysis, based on 16S rRNA sequencing, were applied to select and identify 15 LAB strains from the genera Lactobacillus (n = 11), Pediococcus (n = 2) and Weissella (n = 2). All strains showed resistance to low pH and the evaluated bile salt concentrations in vitro. The API ZYM test characterized the enzymatic activity of the strains, and a high ß-galactosidase activity was observed in 13 strains. All strains presented resistance to simulated gastric (3 h) and intestinal (4 h) conditions in vitro, the ability to auto- and co-aggregate with indicator microorganisms and a high cell surface hydrophobicity. Most of the strains were positive for map and EFTu beneficial genes. All strains exhibited strong deconjugation of bile salts in vitro and all assimilated lactose. CONCLUSIONS: The phenotypes exhibited in vitro and the presence of beneficial genes revealed the beneficial potential of the studied strains, demanding further analyses in a food matrix and in vivo to allow the development of a functional product, with health-related properties.
Assuntos
Laticínios/microbiologia , Lactobacillales/isolamento & purificação , Animais , Bovinos , DNA Bacteriano/genética , Fermentação , Lactobacillales/classificação , Lactobacillales/genética , Lactobacillales/metabolismo , Fenótipo , RNA Ribossômico 16S/genéticaRESUMO
Bacteriocins are antimicrobial peptides produced by bacteria Gram-negative and Gram-positive, including lactic acid bacteria (LAB), organisms that are traditionally used in food preservation practices. Bacteriocins have been shown to have an aptitude as biofilm controlling agents in Listeria monocytogenes biofilms, a major risk for consumers and the food industry. Biofilms protect pathogens from sanitization procedures, allowing them to survive and persist in processing facilities, resulting in the cross-contamination of the end products. Studies have been undertaken on bacteriocinogenic LAB, their bacteriocins, and bioengineered bacteriocin derivatives for controlling L. monocytogenes biofilms on different surfaces through inhibition, competition, exclusion, and displacement. These alternative strategies can be considered promising in preventing the development of resistance to conventional sanitizers and disinfectants. Bacteriocins are "friendly" antimicrobial agents, and with high prevalence in nature, they do not have any known associated public health risk. Most trials have been carried out in vitro, on food contact materials such as polystyrene and stainless steel, while there have been few studies performed in situ to consolidate the results observed in vitro. There are strategies that can be employed for prevention and eradication of L. monocytogenes biofilms (such as the establishment of standard cleaning procedures using the available agents at proper concentrations). However, commercial cocktails using alternatives compounds recognized as safe and environmental friendly can be an alternative approach to be applied by the industries in the future.
Assuntos
Bacteriocinas/genética , Biotecnologia , Indústria de Processamento de Alimentos/métodos , Lactobacillales/química , Bacteriocinas/biossíntese , Biofilmes/crescimento & desenvolvimento , Microbiologia de Alimentos , Lactobacillales/genética , Listeria monocytogenes/patogenicidade , Aço InoxidávelRESUMO
The Listeria monocytogenes strains selected in the present study exhibited similar behavior in biofilm formation, independently of the tested conditions (bacteriocin from L. plantarum ST8SH, vancomycin, propolis (a natural antimicrobial product) and EDTA (chelating agent)), individual or in associations. The individual application of vancomycin had better inhibitory activity than that of propolis and EDTA; however, the association of the previously mentioned antimicrobial agents with bacteriocins resulted in better performance. However, when we compared the effects of vancomycin, propolis and EDTA, we could clearly observe that the combined application of bacteriocin and vancomycin was more effective than the combination of bacteriocin and propolis, and bacteriocin and EDTA. Considering the current need to reduce the use of antimicrobials and chemical substances in food processing, propolis can represent an alternative to improve the inhibitory effect of bacteriocins against L. monocytogenes biofilm formation, based on the obtained results. In general, high concentrations of bacteriocin produced by L. plantarum ST8SH were more effective in biofilm inhibition, and similar results were observed for vancomycin and propolis; however, all tested EDTA concentrations had similar effect on biofilm formation.
Las cepas de Listeria monocytogenes seleccionadas en el presente estudio presentaron comportamientos similares en la formación de biofilms, independientemente de los tratamientos a las que fueron sometidas (bacteriocina de Lactobacillus plantarum ST8SH, vancomicina, própolis (produto natural antimicrobiano) y EDTA (agentes quelante)), individual o en combinaciones. La aplicación individual de vancomicina presentó una mejor actividad inhibitoria frente a las aplicaciones individuales de própolis y de EDTA; sin embargo, la combinación de estos agentes antimicrobianos con las bacteriocinas resultó en un mejor desempeño. Se observó claramente que la aplicación combinada de bacteriocina y vancomicina fue más efectiva para controlar el desarrollo de biofilm en comparación con la combinación de la bacteriocina y el própolis o de la combinación de la bacteriocina y el EDTA. Considerando la necesidad actual de reducir el uso de sustancias antimicrobianas y químicas en el procesamiento de alimentos y sobre la base de los resultados obtenidos, se puede afirmar que el própolis representa una alternativa para mejorar el efecto inhibitorio de bacteriocinas contra la formación de biofilm de L. monocytogenes. En general, altas concentraciones de la bacteriocina producida por L. plantarum ST8SH fueron más eficaces en la inhibición del biofilm, y se observaron resultados similares para la vancomicina y el própolis; sin embargo, todas las concentraciones de EDTA evaluadas tuvieron un efecto similar en la formación de biofilm.
Assuntos
Biofilmes , Lactobacillus plantarum , Listeria monocytogenes , Própole , Bacteriocinas/farmacologia , Vancomicina/farmacologia , Ácido Edético , Biofilmes/efeitos dos fármacos , Lactobacillus plantarum/química , Listeria monocytogenes/efeitos dos fármacos , Antibacterianos/farmacologiaRESUMO
The Listeria monocytogenes strains selected in the present study exhibited similar behavior in biofilm formation, independently of the tested conditions (bacteriocin from L. plantarum ST8SH, vancomycin, propolis (a natural antimicrobial product) and EDTA (chelating agent)), individual or in associations. The individual application of vancomycin had better inhibitory activity than that of propolis and EDTA; however, the association of the previously mentioned antimicrobial agents with bacteriocins resulted in better performance. However, when we compared the effects of vancomycin, propolis and EDTA, we could clearly observe that the combined application of bacteriocin and vancomycin was more effective than the combination of bacteriocin and propolis, and bacteriocin and EDTA. Considering the current need to reduce the use of antimicrobials and chemical substances in food processing, propolis can represent an alternative to improve the inhibitory effect of bacteriocins against L. monocytogenes biofilm formation, based on the obtained results. In general, high concentrations of bacteriocin produced by L. plantarum ST8SH were more effective in biofilm inhibition, and similar results were observed for vancomycin and propolis; however, all tested EDTA concentrations had similar effect on biofilm formation.
Assuntos
Biofilmes , Lactobacillus plantarum , Listeria monocytogenes , Antibacterianos/farmacologia , Bacteriocinas/farmacologia , Biofilmes/efeitos dos fármacos , Ácido Edético , Lactobacillus plantarum/química , Listeria monocytogenes/efeitos dos fármacos , Própole , Vancomicina/farmacologiaRESUMO
Lactobacillus sakei subsp. sakei 2a is a bacteriocinogenic lactic acid bacterium isolated from Brazilian pork sausage, capable of inhibiting the growth of microbial pathogens, mainly Listeria monocytogenes. In order to optimize bacteriocin production for industrial applications, this study evaluated the effect of supplementation of MRS broth with glucose, Tween 20, Tween 80, sodium citrate, potassium chloride and cysteine, and effect of the initial pH and temperature of incubation of the medium on production of bacteriocins by L. sakei 2a. Adding glucose and Tween 20 to the medium, an initial pH of 5.0 or 5.5, and incubation temperatures of 25 °C or 30 °C resulted to the highest bacteriocin yields. Thus, a 2(4) factorial design with the four variables was performed, and statistical analysis showed that it was an adequate model (R (2) = 0.8296). In the studied range, the four parameters significantly influenced bacteriocin production, with the maximum yield produced at an initial pH between 5.5 and 7.0, a temperature between 25 and 30 °C and supplementation of the MRS broth with glucose from 3.25 to 6.0 g L(-1) and Tween 20 from 0.575 to 1.15% (v/v). Response Surface Methodology analysis indicated that the highest bacteriocin production (12800 AU mL(-1)) occurred in the MRS broth supplemented with 5.5 g L(-1) glucose and 1.05% Tween 20 at an initial pH of 6.28 and an incubation temperature of 25 °C. The amount of bacteriocin produced in commercial MRS broths under the same conditions was only 5600AU mL(-1).
Assuntos
Antibacterianos/metabolismo , Bacteriocinas/metabolismo , Meios de Cultura/metabolismo , Lactobacillus/crescimento & desenvolvimento , Lactobacillus/metabolismo , Brasil , Glucose/metabolismo , Lactobacillus/classificação , Testes de Sensibilidade Microbiana , Polissorbatos/metabolismo , Carne Vermelha/microbiologia , Propriedades de Superfície , TemperaturaRESUMO
Assuntos
Antibacterianos/metabolismo , Bacteriocinas/metabolismo , Meios de Cultura/metabolismo , Lactobacillus/crescimento & desenvolvimento , Lactobacillus/metabolismo , Brasil , Glucose/metabolismo , Lactobacillus/classificação , Testes de Sensibilidade Microbiana , Polissorbatos/metabolismo , Carne Vermelha/microbiologia , Propriedades de Superfície , TemperaturaRESUMO
Assuntos
Antibacterianos/metabolismo , Bacteriocinas/metabolismo , Meios de Cultura/metabolismo , Lactobacillus/crescimento & desenvolvimento , Lactobacillus/metabolismo , Brasil , Glucose/metabolismo , Lactobacillus/classificação , Testes de Sensibilidade Microbiana , Polissorbatos/metabolismo , Carne Vermelha/microbiologia , Propriedades de Superfície , TemperaturaRESUMO
Listeria monocytogenes is a pathogen frequently found in dairy products. Its control in fresh cheeses is difficult, due to the psychrotrophic properties and salt tolerance. Bacteriocinogenic lactic acid bacteria (LAB) with proven in vitro antilisterial activity can be an innovative technological approach but their application needs to be evaluated by means of in situ tests. In this study, a novel bacteriocinogenic Lactococcus lactis strain ( Lc . lactis DF4Mi), isolated from raw goat milk, was tested for control of growth of L. monocytogenes in artificially contaminated fresh Minas type goat cheese during storage under refrigeration. A bacteriostatic effect was achieved, and counts after 10 days were 3 log lower than in control cheeses with no added LAB. However, this effect did not differ significantly from that obtained with a non-bacteriocinogenic Lc. lactis strain. Addition of nisin (12.5 mg/kg) caused a rapid decrease in the number of viable L. monocytogenes in the cheeses, suggesting that further studies with the purified bacteriocin DF4Mi may open new possibilities for this strain as biopreservative in dairy products.
Assuntos
Antibiose , Bacteriocinas/metabolismo , Queijo/microbiologia , Cabras , Lactococcus lactis/isolamento & purificação , Listeria monocytogenes/efeitos dos fármacos , Leite/microbiologia , Animais , Carga Bacteriana , Conservação de Alimentos/métodos , Inocuidade dos Alimentos/métodos , Lactococcus lactis/metabolismoRESUMO
Listeria monocytogenes is a pathogen frequently found in dairy products. Its control in fresh cheeses is difficult, due to the psychrotrophic properties and salt tolerance. Bacteriocinogenic lactic acid bacteria (LAB) with proven in vitro antilisterial activity can be an innovative technological approach but their application needs to be evaluated by means of in situ tests. In this study, a novel bacteriocinogenic Lactococcus lactis strain (Lc. lactis DF4Mi), isolated from raw goat milk, was tested for control of growth of L. monocytogenes in artificially contaminated fresh Minas type goat cheese during storage under refrigeration. A bacteriostatic effect was achieved, and counts after 10 days were 3 log lower than in control cheeses with no added LAB. However, this effect did not differ significantly from that obtained with a non-bacteriocinogenic Lc. lactis strain. Addition of nisin (12.5 mg/kg) caused a rapid decrease in the number of viable L. monocytogenes in the cheeses, suggesting that further studies with the purified bacteriocin DF4Mi may open new possibilities for this strain as biopreservative in dairy products.
Assuntos
Animais , Antibiose , Bacteriocinas/metabolismo , Queijo/microbiologia , Cabras , Lactococcus lactis/isolamento & purificação , Listeria monocytogenes/efeitos dos fármacos , Leite/microbiologia , Carga Bacteriana , Conservação de Alimentos/métodos , Inocuidade dos Alimentos/métodos , Lactococcus lactis/metabolismoRESUMO
Listeria monocytogenes is a pathogen frequently found in dairy products. Its control in fresh cheeses is difficult, due to the psychrotrophic properties and salt tolerance. Bacteriocinogenic lactic acid bacteria (LAB) with proven in vitro antilisterial activity can be an innovative technological approach but their application needs to be evaluated by means of in situ tests. In this study, a novel bacteriocinogenic Lactococcus lactis strain (Lc. lactis DF4Mi), isolated from raw goat milk, was tested for control of growth of L. monocytogenes in artificially contaminated fresh Minas type goat cheese during storage under refrigeration. A bacteriostatic effect was achieved, and counts after 10 days were 3 log lower than in control cheeses with no added LAB. However, this effect did not differ significantly from that obtained with a non-bacteriocinogenic Lc. lactis strain. Addition of nisin (12.5 mg/kg) caused a rapid decrease in the number of viable L. monocytogenes in the cheeses, suggesting that further studies with the purified bacteriocin DF4Mi may open new possibilities for this strain as biopreservative in dairy products.(AU)
Assuntos
Animais , Antibiose , Bacteriocinas/metabolismo , Queijo/microbiologia , Lactococcus lactis/isolamento & purificação , Listeria monocytogenes , Leite/microbiologia , Carga Bacteriana , Conservação de Alimentos/métodos , Inocuidade dos Alimentos/métodos , Lactococcus lactis/metabolismoRESUMO
Lactic acid bacteria capable of producing bacteriocins and presenting probiotic potential open innovative technological applications in the dairy industry. In this study, a bacteriocinogenic strain (Lactococcus lactis subsp. lactis DF4Mi) was isolated from goat milk, and studied for its probiotic potential. Lc. lactis DF4Mi was resistant to acidic pH and oxbile, presented co-aggregation with Listeria monocytogenes, and was not affected by several drugs from different generic groups, being sensitive to most tested antibiotics. These properties indicate that this Lc. lactis strain can be used for enhancement of dairy foods safety and quality, in combination with potential probiotic properties.
Assuntos
Bacteriocinas/metabolismo , Cabras , Lactococcus lactis/isolamento & purificação , Lactococcus lactis/metabolismo , Leite/microbiologia , Probióticos , Animais , Aderência Bacteriana , Bile/metabolismo , Inocuidade dos Alimentos/métodos , Concentração de Íons de Hidrogênio , Lactococcus lactis/efeitos dos fármacos , Listeria monocytogenes/fisiologia , Viabilidade Microbiana/efeitos dos fármacosRESUMO
Lactic acid bacteria capable of producing bacteriocins and presenting probiotic potential open innovative technological applications in the dairy industry. In this study, a bacteriocinogenic strain (Lactococcus lactis subsp. lactis DF4Mi) was isolated from goat milk, and studied for its antimicrobial activity. The bacteriocin presented a broad spectrum of activity, was sensitive to proteolytic enzymes, resistant to heat and pH extremes, and not affected by the presence of SDS, Tween 20, Tween 80, EDTA or NaCl. Bacteriocin production was dependent on the components of the culture media, especially nitrogen source and salts. When tested by PCR, the bacteriocin gene presented 100% homology to nisin Z gene. These properties indicate that this L. lactis subsp. lactis DF4Mi can be used for enhancement of dairy foods safety and quality.
Assuntos
Animais , Antibacterianos/metabolismo , Bacteriocinas/metabolismo , Lactococcus lactis/metabolismo , Leite/microbiologia , Sequência de Aminoácidos , Antibacterianos/química , Proteínas de Bactérias/química , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Bacteriocinas/química , Bacteriocinas/genética , Meios de Cultura/química , Detergentes , DNA Bacteriano/genética , Cabras , Concentração de Íons de Hidrogênio , Lactococcus lactis/crescimento & desenvolvimento , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Estabilidade Proteica , Análise de Sequência de DNA , Homologia de Sequência de Aminoácidos , Cloreto de Sódio/metabolismo , TemperaturaRESUMO
Lactic acid bacteria capable of producing bacteriocins and presenting probiotic potential open innovative technological applications in the dairy industry. In this study, a bacteriocinogenic strain (Lactococcus lactis subsp. lactis DF4Mi) was isolated from goat milk, and studied for its antimicrobial activity. The bacteriocin presented a broad spectrum of activity, was sensitive to proteolytic enzymes, resistant to heat and pH extremes, and not affected by the presence of SDS, Tween 20, Tween 80, EDTA or NaCl. Bacteriocin production was dependent on the components of the culture media, especially nitrogen source and salts. When tested by PCR, the bacteriocin gene presented 100% homology to nisin Z gene. These properties indicate that this L. lactis subsp. lactis DF4Mi can be used for enhancement of dairy foods safety and quality.
Assuntos
Animais , Antibacterianos/metabolismo , Bacteriocinas/metabolismo , Lactococcus lactis/metabolismo , Leite/microbiologia , Sequência de Aminoácidos , Antibacterianos/química , Proteínas de Bactérias/química , Bacteriocinas/genética , Meios de Cultura/química , Detergentes , DNA Bacteriano/genética , Cabras , Lactococcus lactis/crescimento & desenvolvimento , Dados de Sequência Molecular , Reação em Cadeia da PolimeraseRESUMO
Lactic acid bacteria capable of producing bacteriocins and presenting probiotic potential open innovative technological applications in the dairy industry. In this study, a bacteriocinogenic strain (Lactococcus lactis subsp. lactis DF4Mi) was isolated from goat milk, and studied for its probiotic potential. Lc. lactis DF4Mi was resistant to acidic pH and oxbile, presented co-aggregation with Listeria monocytogenes, and was not affected by several drugs from different generic groups, being sensitive to most tested antibiotics. These properties indicate that this Lc. lactis strain can be used for enhancement of dairy foods safety and quality, in combination with potential probiotic properties.
Assuntos
Animais , Bacteriocinas/metabolismo , Cabras , Lactococcus lactis/isolamento & purificação , Lactococcus lactis/metabolismo , Leite/microbiologia , Probióticos , Aderência Bacteriana , Bile/metabolismo , Inocuidade dos Alimentos/métodos , Concentração de Íons de Hidrogênio , Lactococcus lactis/efeitos dos fármacos , Listeria monocytogenes/fisiologia , Viabilidade Microbiana/efeitos dos fármacosRESUMO
Lactic acid bacteria capable of producing bacteriocins and presenting probiotic potential open innovative technological applications in the dairy industry. In this study, a bacteriocinogenic strain (Lactococcus lactis subsp. lactis DF4Mi) was isolated from goat milk, and studied for its probiotic potential. Lc. lactis DF4Mi was resistant to acidic pH and oxbile, presented co-aggregation with Listeria monocytogenes, and was not affected by several drugs from different generic groups, being sensitive to most tested antibiotics. These properties indicate that this Lc. lactis strain can be used for enhancement of dairy foods safety and quality, in combination with potential probiotic properties.
Assuntos
Animais , Bacteriocinas/metabolismo , Cabras , Lactococcus lactis/isolamento & purificação , Lactococcus lactis/metabolismo , Leite/microbiologia , Probióticos , Aderência Bacteriana , Bile/metabolismo , Inocuidade dos Alimentos/métodos , Concentração de Íons de Hidrogênio , Lactococcus lactis/efeitos dos fármacos , Listeria monocytogenes/fisiologia , Viabilidade Microbiana/efeitos dos fármacosRESUMO
Lactic acid bacteria capable of producing bacteriocins and presenting probiotic potential open innovative technological applications in the dairy industry. In this study, a bacteriocinogenic strain (Lactococcus lactis subsp. lactis DF4Mi) was isolated from goat milk, and studied for its antimicrobial activity. The bacteriocin presented a broad spectrum of activity, was sensitive to proteolytic enzymes, resistant to heat and pH extremes, and not affected by the presence of SDS, Tween 20, Tween 80, EDTA or NaCl. Bacteriocin production was dependent on the components of the culture media, especially nitrogen source and salts. When tested by PCR, the bacteriocin gene presented 100% homology to nisin Z gene. These properties indicate that this L. lactis subsp. lactis DF4Mi can be used for enhancement of dairy foods safety and quality.
Assuntos
Antibacterianos/metabolismo , Bacteriocinas/metabolismo , Lactococcus lactis/metabolismo , Leite/microbiologia , Sequência de Aminoácidos , Animais , Antibacterianos/química , Proteínas de Bactérias/química , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Bacteriocinas/química , Bacteriocinas/genética , Meios de Cultura/química , DNA Bacteriano/genética , Detergentes , Cabras , Concentração de Íons de Hidrogênio , Lactococcus lactis/crescimento & desenvolvimento , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Estabilidade Proteica , Análise de Sequência de DNA , Homologia de Sequência de Aminoácidos , Cloreto de Sódio/metabolismo , TemperaturaRESUMO
Capability to produce antilisterial bacteriocins by lactic acid bacteria (LAB) can be explored by the food industry as a tool to increase the safety of foods. Furthermore, probiotic activity of bacteriogenic LAB brings extra advantages to these strains, as they can confer health benefits to the consumer. Beneficial effects depend on the ability of the probiotic strains to maintain viability in the food during shelf-life and to survive the natural defenses of the host and multiply in the gastrointestinal tract (GIT). This study evaluated the probiotic potential of a bacteriocinogenic Lactobacillus plantarum strain (Lb. plantarum ST16Pa) isolated from papaya fruit and studied the effect of encapsulation in alginate on survival in conditions simulating the human GIT. Good growth of Lb. plantarum ST16Pa was recorded in MRS broth with initial pH values between 5.0 and 9.0 and good capability to survive in pH 4.0, 11.0 and 13.0. Lb. plantarum ST16Pa grew well in the presence of oxbile at concentrations ranging from 0.2 to 3.0%. The level of auto-aggregation was 37%, and various degrees of co-aggregation were observed with different strains of Lb. plantarum, Enterococcus spp., Lb. sakei and Listeria, which are important features for probiotic activity. Growth was affected negatively by several medicaments used for human therapy, mainly anti-inflammatory drugs and antibiotics. Adhesion to Caco-2 cells was within the range reported for other probiotic strains, and PCR analysis indicated that the strain harbored the adhesion genes mapA, mub and EF-Tu. Encapsulation in 2, 3 and 4% alginate protected the cells from exposure to 1 or 2% oxbile added to MRS broth. Studies in a model simulating the transit through the GIT indicated that encapsulated cells were protected from the acidic conditions in the stomach but were less resistant when in conditions simulating the duodenum, jejunum, ileum and first section of the colon. To our knowledge, this is the first report on a bacteriocinogenic LAB isolated from papaya that presents application in food biopreservation and may be beneficial to the consumer health due to its potential probiotic characteristics.
Assuntos
Lactobacillus plantarum/isolamento & purificação , Lactobacillus plantarum/fisiologia , Viabilidade Microbiana/efeitos dos fármacos , Probióticos/farmacologia , Ácidos/toxicidade , Alginatos/metabolismo , Aderência Bacteriana , Bacteriocinas/metabolismo , Ácidos e Sais Biliares/toxicidade , Carica/microbiologia , Portadores de Fármacos/metabolismo , Células Epiteliais/microbiologia , Ácido Glucurônico/metabolismo , Ácidos Hexurônicos/metabolismo , Concentração de Íons de Hidrogênio , Lactobacillus plantarum/crescimento & desenvolvimento , Lactobacillus plantarum/metabolismoRESUMO
Mastitis is considered to be the most costly disease affecting the dairy industry. Management strategies involve the extensive use of antibiotics to treat and prevent this disease. Prophylactic dosages of antibiotics used in mastitis control programmes could select for strains with resistance to antibiotics. In addition, a strong drive towards reducing antibiotic residues in animal food products has lead to research in finding alternative antimicrobial agents. In this review we have focus on the pathogenesis of the mastitis in dairy cows, existing antibiotic treatments and possible alternative for application of bacteriocins from lactic acid bacteria in the treatment and prevention of this disease.